WRIGHT TIMOTHY MICHAEL 4
4 · Regulus Therapeutics Inc. · Filed Feb 6, 2019
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-02-05+40,000→ 40,000 totalExercise: $0.95Exp: 2029-02-04→ Common Stock (40,000 underlying) - Award
Common Stock
2019-02-05$0.95/sh+40,000$38,000→ 62,893 total
Footnotes (2)
- [F1]Restricted Stock Units which vest ratably on a quarterly basis such that the grant is fully vested on December 31, 2019, subject to the reporting person's continuous service to Regulus through each such vesting date.
- [F2]The stock option will vest ratably on a monthly basis over a 48 month period subject to the reporting person's continuous service to Regulus through each such vesting date.